VAERS reports by lot

Moderna COVID-19 lot 011620A: VAERS reports

42 VAERS reports list lot 011620A as a Moderna COVID-19 vaccine, received between 2021-01-08 and 2023-08-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
42
Reports
12%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4522%
Injection-site / Local reaction3517%
Musculoskeletal2814%
Gastrointestinal2211%
Neurological2110%
Cardiac / Cardiovascular199%
Dermatological (non-injection-site)94%
Respiratory73%
Allergic / Anaphylactic52%
Autoimmune / Immune-mediated42%
Thrombotic / Hematological31%
Psychiatric / Neuropsychiatric31%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas6
New York6
New Jersey5
Florida5
Ohio3
Maine2
Utah2
West Virginia2
Massachusetts1
Indiana1
California1
Illinois1

Reports by month received

2021-0115
2021-023
2021-031
2021-041
2021-061
2021-072
2021-0811
2021-093
2021-102
2021-111
2022-091
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.